Dr. Coulter conducts physiological studies examining mechanisms of epilepsy. His research centers on injury-induced epilepsies as well as genetically-induced epilepsy, autism, and developmental intellectual disabilities.
Dr. Takano's research focuses on basic epilepsy and related neuroscience research centered on advanced optical imaging techniques such as fluorescence lifetime imaging and two-photon microscopy; and application of micro- and nanotechnology like graphene transparent electrode to functional cellular imaging.
Dr. Marsh's research program focuses on understanding how changes in brain development lead to epilepsy, intellectual disability, and autism. He combines molecular and physiological tools in mouse models to ask questions about the interaction of normal development with single gene mutations to determine how the brain responds to perturbations in development.
Dr. Dlugos is the director of the Section of Clinical Neurophysiology at Children’s Hospital of Philadelphia. He studies epilepsy genetics, pharmacogenetics, and epilepsy surgery. He is also a core faculty member of the ENGIN Frontier Program.
Dr. Goldberg's research program focuses on investigating cerebral cortical circuit function and dysfunction in neurodevelopmental disorders. Using a variety of research techniques, Dr. Goldberg has a specific research interest in the workings of neuron subtype called GABAergic inhibitory interneuron and the role of interneuron dysfunction in disease.
Dr. Ortiz-Gonzalez is a physician-scientist specializing in pediatric neurogenetics. Her clinical work focuses on finding a unifying genetic diagnosis for children with rare neurodevelopmental disorders. Her research is informed by her patients and focuses on understanding how genetic changes, in particular those affecting mitochondrial function, cause disease so we can develop better treatments for these children in the future.
Dr. Licht is the director of the Wolfson Family Laboratory for Clinical and Biomedical Optics. His research focuses on the development and use of novel noninvasive optical devices to probe cerebrovascular hemodynamics and physiology in vivo. These devices are used in clinical and preclinical studies to discover the timing and causes of brain injury during care.